Drug intelligence / Profile preview

pinocembrin

Development stage
Phase 2
Lead developer
Chinese Academy of Medical Sciences
Modality
Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Administration
Intravenous
01

Overview

Pinocembrin is a natural flavonoid (5,7-dihydroxyflavanone) found in various plants such as Pinus heartwood, Eucalyptus, Populus species, and propolis. It exhibits a wide range of pharmacological activities including antioxidant, anti-inflammatory, antimicrobial, antineoplastic (anticancer), vasodilator and neuroprotective effects. Mechanistically, pinocembrin acts through multiple pathways—reducing oxidative stress by scavenging reactive oxygen species (ROS), modulating mitochondrial function via the Erk1/2-Nrf2 axis to enhance cellular resilience against ischemic injury and neurodegeneration[8]. It also suppresses pro-inflammatory cytokines and microglial activation in the central nervous system[5][8], inhibits apoptosis in neuronal cells by regulating Bcl-2/Bax ratio and cytochrome C release[8], irreversibly inhibits CYP3A4 enzyme activity[8], and blocks organic anion transporting polypeptides hOATP2B1/hOATP1A2[8]. Pinocembrin has been investigated for its potential to treat ischemic stroke (phase II clinical trials)[7][6] due to its neuroprotective properties. Additional research supports roles in improving cognitive function in models of Alzheimer’s disease and reducing susceptibility to atrial fibrillation by modulating cardiac electrophysiology[10].

Other names
5,7-dihydroxyflavanone(+)-pinocembringalangin flavanonedihydrochrysin
02

Targets

SLCO2B1 (Organic anion transporting polypeptide 2B1)CYP3A4 (Cytochrome P450 3A4)OATP1A2 (Solute carrier organic anion transporter family member 1A2)

Beyond the preview

Go deeper on pinocembrin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on pinocembrin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call